Possible vaccine for mesothelioma proven safe
March 3, 2010 by admin · Leave a Comment
Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient’s own dendritic cells (DC) with antigen from the patient’s tumor, was able to induce a T-cell response against mesothelioma tumors.
Experimental vaccine protects monkeys against chikungunya
March 3, 2010 by admin · Leave a Comment
Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston Read more
HIV vaccine strategy expands immune responses
March 2, 2010 by admin · Leave a Comment
Contact: James E. Rickman
jamesr@lanl.gov
505-665-9203
DOE/Los Alamos National Laboratory Read more
Pneumococcal vaccine offers protection to HIV-infected African adults in clinical trial
March 2, 2010 by admin · Leave a Comment
Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.
Small molecule with high impact
March 1, 2010 by admin · Leave a Comment
Contact: Dr. Bastian Dornbach
bastian.dornbach@helmholtz-hzi.de
49-053-161-811-407
Helmholtz Association of German Research Centres Read more
New method makes vaccines stable at tropical temperatures
February 16, 2010 by admin · Leave a Comment
Contact: Jonathan Wood
press.office@admin.ox.ac.uk
44-018-652-80530
Wellcome Trust
A simple and cheap way of making vaccines stable even at tropical temperatures has been developed by scientists at Oxford University and Nova Bio-Pharma Technologies.
New method makes vaccines stable at tropical temperatures
February 16, 2010 by admin · Leave a Comment
Contact: Andrew Rea
andy@gravitaspr.co.uk
44-012-422-11000
Gravitas PR Read more
New strategy produces promising advance in cancer vaccines
February 14, 2010 by admin · Leave a Comment
Contact: Adam Dormuth
dormutha@njhealth.org
303-398-1082
National Jewish Medical and Research Center
Researchers at National Jewish Health and the University of Colorado School of Medicine have used a new strategy to develop cancer vaccines that are remarkably effective in mice. In the February 16 issue of the Proceedings of the National Academy of Sciences (PNAS), Kimberly Jordan, PhD, Jill Slansky, PhD, and John Kappler, PhD, report that 100 percent of the mice vaccinated with a peptide they developed remained alive and tumor-free for at least 60 days after inoculation with colon cancer cells. The research suggests a method for developing vaccines against a wide variety of cancers.
Scripps research scientists find potential new way to enhance vaccines
January 26, 2010 by admin · Leave a Comment
Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute Read more
Rotavirus vaccine offers new tool to combat severe diarrhea in developing world
January 26, 2010 by admin · Leave a Comment
Contact: Kate Spark
kate.spark@liv.ac.uk
01-517-942-247
University of Liverpool
Rotavirus is the leading cause of severe, acute gastroenteritis among infants and young children throughout the world and is responsible for an estimated 527,000 deaths among children under five each year. More than 90% of childhood deaths attributed to rotavirus infection occur in developing countries. Symptoms include severe diarrhoea and vomiting, leading to loss of fluid and electrolytes which can result in dehydration, shock, and death.
